Essential Medical announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device.  Nicolas Van Mieghem, Principal Investigator in the EU study, MD, PhD, [...] commented: "I'm looking forward to have the MANTA closure device in my practice for everyday use. Our experience in the CE Mark clearly showed MANTA can change and improve access site management in the field of large-bore interventions"...

Essential Medical announced today the first live MANTA case at the Transcatheter Therapeutics conference (TCT) in Washington DC.  TCT is the largest annual interventional cardiology conference in North America.  The case was performed live on Monday October 31st...

August 2016

Essential Medical announced today that the publication of the MANTA CE marking study results in JACC Interventions titled: "Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access" (http://dx.doi.org/10.1016/j.jcin.2016.12.277)...  

Essential Medical announced today that it has received Investigational Device Exemption (IDE) approval from the FDA to begin the U.S. clinical trial for X-Seal, the company's 6F Vascular Closure Device.  The single-arm, pivotal study will consist of 180 patients at 10-15 sites throughout the U.S., Canada, and the EU...

Essential Medical announced today that it has received Investigational Device Exemption (IDE) approval from the FDA to begin the U.S. clinical trial for MANTA, the company's Large Bore Vascular Closure Device.  The pivotal study will evaluate the safety and efficacy of vascular access closure using MANTA for femoral arterial access sites in patients undergoing percutaneous procedures using sheaths ranging from 10F to 24F...

Essential Medical announced today that it has submitted their CE Mark application for MANTA, the company's Large Bore Vascular Closure Device.  The single arm, 50 patient study shows conclusively that MANTA successfully achieves immediate hemostasis (median TTH was 24 seconds) in the femoral arterial access site in patients undergoing percutaneous large bore procedures using sheaths ranging from 14F to 24F...

May 2016

April 2016

Essential Medical announced today that it has completed a Series B financing of $14.9M. The round was led by Amzak Health along with original Series A investors including DSM Venturing, the venture investment arm of Royal DSM...

November 2016

July 2016

December 2016

​Closure Evolved.

July 2016

September 2016

Essential Medical announced today that the first U.S. clinical trail case was performed on November 28 by Dr. Itsik Ben-Dor, MD at the Washington Hospital Center in Washington D.C.  After successfully implanting a 34mm Medtronic CoreValve Evolut R, the 21F arteriotomy was closed with the 18F MANTA device, which provided immediate hemostasis and a clear patent vessel...